Artivion(AORT)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

AORT Artivion

盘后交易 12-17 16:45:59 EST

47.18

+1.27

+2.77%

盘后47.18

+0.000.00%

16:33 EST

最高48.25	最低45.77	成交量67.29万
今开45.77	昨收45.91	日振幅5.40%
总市值22.35亿	流通市值19.67亿	总股本4,737万
成交额3,189万	换手率1.61%	流通股本4,169万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"AORT","market":"US","secType":"STK","nameCN":"Artivion","latestPrice":47.18,"timestamp":1766005200000,"preClose":45.91,"halted":0,"volume":672930,"hourTrading":{"tag":"盘后","latestPrice":47.18,"preClose":47.18,"latestTime":"16:33 EST","volume":4395,"amount":207356.1,"timestamp":1766007198411},"delay":0,"floatShares":41689172,"shares":47374939,"eps":-0.207628,"marketStatus":"盘后交易","change":1.27,"latestTime":"12-17 16:45:59 EST","open":45.77,"high":48.25,"low":45.77,"amount":31894416.38448,"amplitude":0.054019,"askPrice":47.46,"askSize":10,"bidPrice":46.26,"bidSize":44,"shortable":3,"etf":0,"ttmEps":-0.207628,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1766019600000},"marketStatusCode":4,"adr":0,"listingDate":868939200000,"exchange":"NYSE","adjPreClose":45.91,"postHourTrading":{"tag":"盘后","latestPrice":47.18,"preClose":47.18,"latestTime":"16:33 EST","volume":4395,"amount":207356.1,"timestamp":1766007198411},"volumeRatio":1.95209,"impliedVol":0.2702,"impliedVolPercentile":0.268},"requestUrl":"/m/hq/s/AORT/wiki","defaultTab":"wiki","newsList":[{"id":"2583688446","title":"Artivion, Inc.盘中异动 急速下挫5.04%报45.23美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2583688446","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583688446?lang=zh_cn&edition=full","pubTime":"2025-11-14 01:30","pubTimestamp":1763055021,"startTime":"0","endTime":"0","summary":"北京时间2025年11月14日01时30分，Artivion, Inc.股票出现异动，股价大幅下跌5.04%。截至发稿，该股报45.23美元/股，成交量21.1556万股，换手率0.45%，振幅5.14%。Artivion, Inc.股票所在的医疗器械行业中，整体涨幅为0.64%。Artivion, Inc.公司简介：Artivion Inc为心脏和血管外科医生提供一套以主动脉为中心的解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251114013021976792ef&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251114013021976792ef&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00B19Z4B17.USD","IE00B7SZL793.SGD","AORT","IE0031619046.USD","IE00B66KJ199.SGD","BK4082"],"gpt_icon":0},{"id":"1141223386","title":"Artivion Inc于9月26日签署两项房地产购买协议和销售合同——SEC文件","url":"https://stock-news.laohu8.com/highlight/detail?id=1141223386","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1141223386?lang=zh_cn&edition=full","pubTime":"2025-09-30 04:29","pubTimestamp":1759177754,"startTime":"0","endTime":"0","summary":"Artivion Inc于9月26日签署两项房地产购买协议和销售合同，相关信息已在SEC文件中披露。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AORT","BK4082","IE00B66KJ199.SGD","IE00B7SZL793.SGD","IE0031619046.USD","IE00B19Z4B17.USD"],"gpt_icon":0},{"id":"2558667487","title":"Artivion, Inc.盘中异动 下午盘股价大涨5.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2558667487","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558667487?lang=zh_cn&edition=full","pubTime":"2025-08-12 03:08","pubTimestamp":1754939310,"startTime":"0","endTime":"0","summary":"北京时间2025年08月12日03时08分，Artivion, Inc.股票出现波动，股价急速拉升5.15%。Artivion, Inc.股票所在的医疗器械行业中，整体跌幅为0.35%。其相关个股中，Bluejay Diagnostics, Inc.、Ainos Inc C/Wts 29/07/2027 、Dih Holdings Us Inc C/Wts 20/04/2028 涨幅较大，Bluejay Diagnostics, Inc.、Invo Fertility, Inc.、Nanovibronix, Inc.较为活跃，换手率分别为6058.85%、81.12%、20.78%，振幅较大的相关个股有Ainos Inc C/Wts 29/07/2027 、Dih Holdings Us Inc C/Wts 20/04/2028 、Bluejay Diagnostics, Inc.，振幅分别为62.07%、56.14%、50.71%。Artivion, Inc.公司简介：Artivion Inc为心脏和血管外科医生提供一套以主动脉为中心的解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250812030830a4827431&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250812030830a4827431&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE0031619046.USD","AORT","IE00B66KJ199.SGD","IE00B7SZL793.SGD","BK4082","IE00B19Z4B17.USD"],"gpt_icon":0},{"id":"1156581219","title":"异动解读 | Artivion股价盘中大涨20.76%，业绩超预期且上调全年指引","url":"https://stock-news.laohu8.com/highlight/detail?id=1156581219","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1156581219?lang=zh_cn&edition=full","pubTime":"2025-08-08 21:57","pubTimestamp":1754661443,"startTime":"0","endTime":"0","summary":"医疗设备公司Artivion今日盘中股价大涨20.76%，引发市场广泛关注。这一显著涨幅主要源于公司发布的2025年第二季度财报远超市场预期，并上调了全年业绩指引。调整后EBITDA同比增长33%，达到2480万美元，非GAAP毛利率为65.1%，同比增长50个基点。公司预计全年收入将达到4.35亿至4.43亿美元，调整后EBITDA预计为8600万至9100万美元。投资者对公司的业绩表现和未来前景反应积极，推动股价大幅上涨。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["AORT"],"gpt_icon":1},{"id":"2557520910","title":"Artivion, Inc.盘中异动 股价大涨20.09%报39.27美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2557520910","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557520910?lang=zh_cn&edition=full","pubTime":"2025-08-08 21:33","pubTimestamp":1754660038,"startTime":"0","endTime":"0","summary":"北京时间2025年08月08日21时33分，Artivion, Inc.股票出现异动，股价急速拉升20.09%。Artivion, Inc.股票所在的医疗器械行业中，整体涨幅为0.42%。其相关个股中，Artivion, Inc.、Varex Imaging Corporation、Sight Sciences, Inc.涨幅较大，Invo Fertility, Inc.、Nanovibronix, Inc.、Pavmed Inc.较为活跃，换手率分别为12.45%、10.34%、8.19%，振幅较大的相关个股有Apyx Medical Corporation、Treace Medical Concepts, Inc.、Sight Sciences, Inc.，振幅分别为18.88%、13.56%、10.42%。Artivion, Inc.公司简介：Artivion Inc为心脏和血管外科医生提供一套以主动脉为中心的解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250808213358a47d5bed&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250808213358a47d5bed&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AORT","BK4082","IE00B66KJ199.SGD","IE00B7SZL793.SGD","IE0031619046.USD","IE00B19Z4B17.USD"],"gpt_icon":0},{"id":"1117691826","title":"异动解读 | Artivion股价盘前大涨15.60%，源于第二季度业绩超预期及提高全年指引","url":"https://stock-news.laohu8.com/highlight/detail?id=1117691826","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1117691826?lang=zh_cn&edition=full","pubTime":"2025-08-08 21:14","pubTimestamp":1754658880,"startTime":"0","endTime":"0","summary":"医疗设备公司Artivion今日盘前股价大涨15.60%，主要受益于公司发布的2025年第二季度财报超出市场预期，并上调了全年业绩指引。根据公司公布的财报，Artivion第二季度调整后每股收益为8美分，远超分析师预期的盈亏平衡。公司预计全年收入将达到4.35亿至4.43亿美元，调整后EBITDA预计为8600万至9100万美元。管理层对公司的AMDS产品在美国市场的早期进展表示满意，并对未来的增长和盈利能力充满信心。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["AORT"],"gpt_icon":1},{"id":"1191215435","title":"Artivion 2025财年Q2业绩会总结及问答精华：AMDS美国市场启动与强劲增长","url":"https://stock-news.laohu8.com/highlight/detail?id=1191215435","media":"业绩会速递","labels":["earningsCall","movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1191215435?lang=zh_cn&edition=full","pubTime":"2025-08-08 10:06","pubTimestamp":1754618804,"startTime":"0","endTime":"0","summary":"管理层对AMDS在美国市场的早期进展表示满意，并对未来的增长和盈利能力充满信心。预计AMDS的美国市场启动将带来显著增长，未来还将继续推进临床试验和新产品的市场推广。非GAAP毛利率为65.1%，同比增长50个基点。AMDS的高毛利率将是未来EBITDA增长的重要贡献因素。Artivion在2025年第二季度表现强劲，实现了两位数的收入和调整后EBITDA增长。尽管面临市场竞争和临床试验风险，Artivion凭借其创新产品和强大的市场执行力，有望在未来实现持续增长。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"earningsCall,movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AORT"],"gpt_icon":0},{"id":"2550668472","title":"Artivion, Inc.盘中异动 快速拉升5.13%报32.15美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2550668472","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550668472?lang=zh_cn&edition=full","pubTime":"2025-07-10 03:52","pubTimestamp":1752090773,"startTime":"0","endTime":"0","summary":"北京时间2025年07月10日03时52分，Artivion, Inc.股票出现异动，股价急速拉升5.13%。截至发稿，该股报32.15美元/股，成交量30.4706万股，换手率0.65%，振幅5.23%。Artivion, Inc.股票所在的医疗器械行业中，整体涨幅为0.58%。Artivion, Inc.公司简介：Artivion Inc为心脏和血管外科医生提供一套以主动脉为中心的解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710035254a440e841&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710035254a440e841&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00B19Z4B17.USD","IE00B7SZL793.SGD","AORT","IE0031619046.USD","IE00B66KJ199.SGD","BK4082"],"gpt_icon":0},{"id":"2516376743","title":"Artivion, Inc.2024财年实现净利润-13.36百万美元，同比增加56.30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516376743","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516376743?lang=zh_cn&edition=full","pubTime":"2025-03-01 00:00","pubTimestamp":1740758444,"startTime":"0","endTime":"0","summary":"3月1日，Artivion, Inc.公布财报，公告显示公司2024财年净利润为-13.36百万美元，同比增加56.30%；其中营业收入为3.89亿美元，同比增加9.89%，每股基本收益为-0.32美元。从资产负债表来看，Artivion, Inc.总负债5.13亿美元，其中短期债务5.29百万美元，资产负债比为1.54，流动比率为0.04。机构评级：截至2025年3月1日，当前有6家机构对Artivion, Inc.目标价做出预测，其中目标均价为32.33美元，其中最低目标价为30.00美元，最高目标价为35.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250301000054abe0ffa4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250301000054abe0ffa4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AORT"],"gpt_icon":0},{"id":"2514016991","title":"Citizens Capital Markets：重申Artivion(AORT.US)评级，由优于大市调整至优于大市评级, 目标价由33.00美元调整至33.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2514016991","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514016991?lang=zh_cn&edition=full","pubTime":"2025-02-25 23:41","pubTimestamp":1740498087,"startTime":"0","endTime":"0","summary":"Citizens Capital Markets：重申Artivion(AORT.US)评级，由优于大市调整至优于大市评级, 目标价由33.00美元调整至33.00美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/25234148384497.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["AORT"],"gpt_icon":0},{"id":"2514090314","title":"Artivion, Inc.盘中异动 早盘急速跳水7.36%报25.80美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514090314","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514090314?lang=zh_cn&edition=full","pubTime":"2025-02-25 22:36","pubTimestamp":1740494161,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日22时36分，Artivion, Inc.股票出现异动，股价快速下挫7.36%。截至发稿，该股报25.80美元/股，成交量3747股，换手率0.01%，振幅0.07%。Artivion, Inc.股票所在的医疗器械行业中，整体跌幅为0.01%。Artivion, Inc.公司简介：Artivion Inc 为心脏和血管外科医生提供一套主动脉为中心的解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225223601abdc7f52&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225223601abdc7f52&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4082","IE0031619046.USD","AORT","IE00B66KJ199.SGD","IE00B19Z4B17.USD","IE00B7SZL793.SGD"],"gpt_icon":0},{"id":"1102635029","title":"异动解读 | Artivion营收不及预期 盘后大跌6.64%","url":"https://stock-news.laohu8.com/highlight/detail?id=1102635029","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1102635029?lang=zh_cn&edition=full","pubTime":"2025-02-25 06:02","pubTimestamp":1740434560,"startTime":"0","endTime":"0","summary":"医疗器械公司Artivion(AORT)周一盘后交易中大跌6.64%,因公司最新公布的第四季度业绩未达分析师预期。\n数据显示,Artivion第四季度销售额为9731万美元,较去年同期增长3.88%,但低于分析师预期的1.0082亿美元。季绩不佳导致资金撤离,引发Artivion盘后股价暴跌。\n分析人士指出,医疗器械行业竞争激烈,如果Artivion未来无法实现预期销售增长,将对公司业绩和股价造成进一步压力。市场将持续关注Artivion后续财报,评估其业务发展势头。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["AORT"],"gpt_icon":0},{"id":"1118685764","title":"Artivion第四季度调整后每股收益为$0，低于预期的$-0.06；销售额为$97.31M，低于预期的$100.82M","url":"https://stock-news.laohu8.com/highlight/detail?id=1118685764","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1118685764?lang=zh_cn&edition=full","pubTime":"2025-02-25 05:21","pubTimestamp":1740432065,"startTime":"0","endTime":"0","summary":"Artivion  报告季度销售额为$97.31百万，比分析师的预期$100.82百万低3.48％。这比去年同期$93.67百万的销售额增长了3.88％。以上内容来自Benzinga Earnings专栏，原文如下：$Artivion$  reported quarterly sales of $97.31 million which missed the analyst consensus estimate of $100.82 million by 3.48 percent.  This is a 3.88 percent increase over sales of $93.67 million the same period last year.","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Artivion第四季度调整后每股收益为$0，低于预期的$-0.06；销售额为$97.31M，低于预期的$100.82M","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AORT"],"gpt_icon":0},{"id":"2507458175","title":"Needham：重申Artivion(AORT.US)评级，由买入调整至买入评级, 目标价由34.00美元调整至34.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2507458175","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2507458175?lang=zh_cn&edition=full","pubTime":"2025-01-29 00:30","pubTimestamp":1738081842,"startTime":"0","endTime":"0","summary":"Needham：重申Artivion(AORT.US)评级，由买入调整至买入评级, 目标价由34.00美元调整至34.00美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/01/29003047883380.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["AORT"],"gpt_icon":0},{"id":"2503191879","title":"Artivion, Inc.盘中异动 股价大涨5.30%报31.65美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2503191879","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503191879?lang=zh_cn&edition=full","pubTime":"2025-01-16 22:37","pubTimestamp":1737038253,"startTime":"0","endTime":"0","summary":"北京时间2025年01月16日22时37分，Artivion, Inc.股票出现波动，股价快速拉升5.30%。截至发稿，该股报31.65美元/股，成交量4.3507万股，换手率0.10%，振幅1.76%。Artivion, Inc.股票所在的医疗器械行业中，整体涨幅为0.76%。Artivion, Inc.公司简介：Artivion Inc 为心脏和血管外科医生提供一套主动脉为中心的解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250116223733abad50f5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250116223733abad50f5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4082","IE00B7SZL793.SGD","IE00B66KJ199.SGD","IE00B19Z4B17.USD","IE0031619046.USD","AORT"],"gpt_icon":0},{"id":"2484954369","title":"Artivion, Inc.2024财年第三财季实现净利润-2.29百万美元，同比增加76.54%","url":"https://stock-news.laohu8.com/highlight/detail?id=2484954369","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484954369?lang=zh_cn&edition=full","pubTime":"2024-11-17 00:02","pubTimestamp":1731772953,"startTime":"0","endTime":"0","summary":"11月17日，Artivion, Inc.公布财报，公告显示公司2024财年第三财季净利润为-2.29百万美元，同比增加76.54%；其中营业收入为95.78百万美元，同比增加9.03%，每股基本收益为-0.05美元。从资产负债表来看，Artivion, Inc.总负债4.98亿美元，其中短期债务1.05亿美元，资产负债比为1.62，流动比率为1.56。机构评级：截至2024年11月17日，当前有6家机构对Artivion, Inc.目标价做出预测，其中目标均价为33.17美元，其中最低目标价为32.00美元，最高目标价为35.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241117000322a23e064e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241117000322a23e064e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AORT"],"gpt_icon":0},{"id":"2481310298","title":"Artivion, Inc.盘中异动 快速下跌5.66%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481310298","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481310298?lang=zh_cn&edition=full","pubTime":"2024-11-08 22:45","pubTimestamp":1731077149,"startTime":"0","endTime":"0","summary":"北京时间2024年11月08日22时45分，Artivion, Inc.股票出现异动，股价急速下挫5.66%。Artivion, Inc.股票所在的医疗器械行业中，整体涨幅为0.55%。其相关个股中，Tivic Health Systems, Inc.、Nexalin Technology Inc C/Wts 、Lensar, Inc.涨幅较大，Tivic Health Systems, Inc.、Bluejay Diagnostics, Inc.、Ainos, Inc.较为活跃，换手率分别为2786.95%、13.00%、9.91%，振幅较大的相关个股有Tivic Health Systems, Inc.、Clearpoint Neuro Inc.、Pacific Biosciences Of California, Inc.，振幅分别为84.61%、20.86%、19.18%。Artivion, Inc.公司简介：Artivion Inc 为心脏和血管外科医生提供一套主动脉为中心的解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241108224549971a5623&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241108224549971a5623&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AORT","IE00B66KJ199.SGD","IE00B7SZL793.SGD","IE00B19Z4B17.USD","BK4082","IE0031619046.USD"],"gpt_icon":0},{"id":"2481983610","title":"Artivion, Inc.盘中异动 早盘大幅拉升5.74%报29.49美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2481983610","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481983610?lang=zh_cn&edition=full","pubTime":"2024-11-06 22:31","pubTimestamp":1730903505,"startTime":"0","endTime":"0","summary":"北京时间2024年11月06日22时31分，Artivion, Inc.股票出现异动，股价急速上涨5.74%。截至发稿，该股报29.49美元/股，成交量1.7448万股，换手率0.04%，振幅3.08%。Artivion, Inc.股票所在的医疗器械行业中，整体涨幅为1.59%。Artivion, Inc.公司简介：Artivion Inc 为心脏和血管外科医生提供一套主动脉为中心的解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241106223145971a4bb8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241106223145971a4bb8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00B66KJ199.SGD","AORT","IE00B19Z4B17.USD","BK4082","IE00B7SZL793.SGD","IE0031619046.USD"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.artivion.com","stockEarnings":[{"period":"1week","weight":0.0615},{"period":"1month","weight":0.0046},{"period":"3month","weight":0.1492},{"period":"6month","weight":0.5458},{"period":"1year","weight":0.5853},{"period":"ytd","weight":0.6058}],"compareEarnings":[{"period":"1week","weight":-0.0061},{"period":"1month","weight":0.0103},{"period":"3month","weight":0.0299},{"period":"6month","weight":0.1363},{"period":"1year","weight":0.1188},{"period":"ytd","weight":0.1583}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Artivion, Inc.于 1984 年在佛罗里达州注册成立，并于2022年1月1日将其注册地址从佛罗里达州更改为特拉华州，是生产，加工和分销医疗器械和植入式人体组织的领先企业，专注于主动脉修复。 他们的医疗设备和加工组织主要包括四个产品系列：BioGlue外科胶粘剂（“BioGlue”）; On-X机械心脏瓣膜和手术产品; JOTEC血管内和外科产品; 以及包括CryoValve SG肺心脏瓣膜（“CryoValve SGPV”）和CryoPatch SG肺心脏贴片（“CryoPatch SG”）在内的心脏和血管人体组织，两者均使用其专有的SynerGraft技术加工。 其他产品包括CardioGenesis心脏激光疗法，PerClot和PhotoFixTM。","yearOnYearQuotes":[{"month":1,"riseRate":0.4375,"avgChangeRate":0.010603},{"month":2,"riseRate":0.5,"avgChangeRate":0.006023},{"month":3,"riseRate":0.393939,"avgChangeRate":-0.010393},{"month":4,"riseRate":0.606061,"avgChangeRate":0.06644},{"month":5,"riseRate":0.515152,"avgChangeRate":0.06459},{"month":6,"riseRate":0.666667,"avgChangeRate":0.033318},{"month":7,"riseRate":0.515152,"avgChangeRate":-0.003423},{"month":8,"riseRate":0.484848,"avgChangeRate":0.022369},{"month":9,"riseRate":0.636364,"avgChangeRate":0.033318},{"month":10,"riseRate":0.393939,"avgChangeRate":-0.030211},{"month":11,"riseRate":0.545455,"avgChangeRate":0.017167},{"month":12,"riseRate":0.515152,"avgChangeRate":0.022312}],"exchange":"NYSE","name":"Artivion","nameEN":"Artivion"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Artivion(AORT)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Artivion(AORT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Artivion,AORT,Artivion股票,Artivion股票老虎,Artivion股票老虎国际,Artivion行情,Artivion股票行情,Artivion股价,Artivion股市,Artivion股票价格,Artivion股票交易,Artivion股票购买,Artivion股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Artivion(AORT)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Artivion(AORT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}